- Home
- Publications
- Publication Search
- Publication Details
Title
Raf kinases in cancer–roles and therapeutic opportunities
Authors
Keywords
-
Journal
ONCOGENE
Volume 30, Issue 32, Pages 3477-3488
Publisher
Springer Nature
Online
2011-05-16
DOI
10.1038/onc.2011.160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Constitutive Activation of Raf-1 Induces Glioma Formation in Mice
- (2015) Yelena Lyustikman et al. NEOPLASIA
- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A
- (2011) Imanol Arozarena et al. CANCER CELL
- RAF inhibition and induction of cutaneous squamous cell carcinoma
- (2011) Caroline Robert et al. CURRENT OPINION IN ONCOLOGY
- Biological challenges of BRAF inhibitor therapy
- (2011) Igor Puzanov et al. Molecular Oncology
- Targeting BRAF for patients with melanoma
- (2010) H-T Arkenau et al. BRITISH JOURNAL OF CANCER
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- BRAF Inactivation Drives Aneuploidy by Deregulating CRAF
- (2010) T. Kamata et al. CANCER RESEARCH
- Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
- (2010) A. Boni et al. CANCER RESEARCH
- Targets of Raf in tumorigenesis
- (2010) T. S. Niault et al. CARCINOGENESIS
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Does Basal Cell Carcinoma Belong to the Spectrum of Sorafenib-Induced Epithelial Skin Cancers?
- (2010) A. Degen et al. DERMATOLOGY
- V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation ofp16INK4a
- (2010) Linda A. S. Carragher et al. EMBO Molecular Medicine
- Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo
- (2010) A. Beliveau et al. GENES & DEVELOPMENT
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
- (2010) Nallasivam Palanisamy et al. NATURE MEDICINE
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Partner exchange: protein–protein interactions in the Raf pathway
- (2010) Reiner Wimmer et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes
- (2009) Hong Yu et al. AMERICAN JOURNAL OF PATHOLOGY
- Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
- (2009) Nathalie Dhomen et al. CANCER CELL
- Raf-1 Addiction in Ras-Induced Skin Carcinogenesis
- (2009) Karin Ehrenreiter et al. CANCER CELL
- Sorafenib Inhibits Non-Small Cell Lung Cancer Cell Growth by Targeting B-RAF in KRAS Wild-Type Cells and C-RAF in KRAS Mutant Cells
- (2009) K. Takezawa et al. CANCER RESEARCH
- The BRAFV600E Oncogene Induces Transforming Growth Factor Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer
- (2009) G. Riesco-Eizaguirre et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
- (2009) William E Tidyman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7
- (2009) Surabhi Dangi-Garimella et al. EMBO JOURNAL
- Identification of Novelin VivoPhosphorylation Sites of the Human Proapoptotic Protein BAD
- (2009) Lisa Polzien et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations
- (2009) A Zebisch et al. LEUKEMIA
- Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
- (2009) D. A. Ritt et al. MOLECULAR AND CELLULAR BIOLOGY
- Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
- (2009) William M. Old et al. MOLECULAR CELL
- Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
- (2009) Bin Zheng et al. MOLECULAR CELL
- C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
- (2009) Florian A. Karreth et al. MOLECULAR CELL
- A dimerization-dependent mechanism drives RAF catalytic activation
- (2009) Thanashan Rajakulendran et al. NATURE
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
- (2009) Federica Catalanotti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells
- (2009) G M Argast et al. ONCOGENE
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
- (2009) D T W Jones et al. ONCOGENE
- Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
- (2009) V K Goel et al. ONCOGENE
- V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
- (2009) C. A. Pratilas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells
- (2008) Y. Dai et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- A Small Molecule Disruptor of Rb/Raf-1 Interaction Inhibits Cell Proliferation, Angiogenesis, and Growth of Human Tumor Xenografts in Nude Mice
- (2008) R. Kinkade et al. CANCER RESEARCH
- Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
- (2008) M. Cheung et al. CANCER RESEARCH
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
- Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives
- (2008) Y. Fukuyo et al. CANCER RESEARCH
- Tumour cell survival signalling by the ERK1/2 pathway
- (2008) K Balmanno et al. CELL DEATH AND DIFFERENTIATION
- Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor
- (2008) Alexey E Granovsky et al. CELL RESEARCH
- The TGFß pathway as a therapeutic target in cancer
- (2008) Joan Seoane Clinical & Translational Oncology
- Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target
- (2008) Lingchun Zeng et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival
- (2008) Paulo Matos et al. GASTROENTEROLOGY
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Survival Signaling by C-RAF: Mitochondrial Reactive Oxygen Species and Ca2+ Are Critical Targets
- (2008) A. V. Kuznetsov et al. MOLECULAR AND CELLULAR BIOLOGY
- B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic β-cell carcinogenesis
- (2008) I Sobczak et al. ONCOGENE
- C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
- (2008) D Zhuang et al. ONCOGENE
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B-RAF Regulation of Rnd3 Participates in Actin Cytoskeletal and Focal Adhesion Organization
- (2007) R. Matthew Klein et al. MOLECULAR BIOLOGY OF THE CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now